Skip to Content

Home
About
Our Science
Programs & Pipeline
- Pipeline
- Clinical Trials
Patient Focus
- Patient Stories
- Disease Focus
Investors & Media

Careers
Contact

menu

Press Kit

Overview
Press Releases
Scientific Publications & Presentations
Corporate Presentation
Events
Press Kit
Corporate Governance
Financial Info
Analyst Coverage
Investor Resources

Logo Downloads

Intellia Logo

Intellia Logo (reversed)
Photo Downloads

Intellia Therapeutics headquarters in Cambridge, Mass.
Infographic Downloads

Intellia Therapeutics: About Transthyretin (ATTR) Amyloidosis

Intellia Therapeutics: About Hereditary Angioedema (HAE)

Intellia Therapeutics: Nex-z (NTLA-2001) Intended MOA

Intellia Therapeutics: Lonvo-z (NTLA-2002) Intended MOA
Leadership Headshots

John Leonard, M.D.

President and
Chief Executive Officer

James Basta, J.D.

Executive Vice President,
General Counsel and Corporate Secretary

Edward Dulac

Executive Vice President,
Chief Financial Officer

Birgit Schultes, Ph.D.

Executive Vice President,
Chief Scientific Officer
Scientific Publications & Presentations

Scientific Publications & Presentations

Intellia Therapeutics
CRISPR/Cas9 Resources

What is Genome Editing?

American Society of Gene and Cell Therapy

CRISPR/Cas9 – How it Works (Video)

Intellia Therapeutics

The Nobel Prize in Chemistry 2020

The Royal Swedish Academy of Sciences

What are genome editing and CRISPR-Cas9?

National Institutes of Health, Genetic Home Reference

Stay in the Know

Get Intellia’s press releases delivered to your inbox

Contacts

Jason Fredette

VP, Investor Relations & Corporate Communications

[email protected]

Follow Us on

Social Media

© 2026. Intellia Therapeutics, Inc.

Intellia Therapeutics and the Intellia Therapeutics logo are registered trademarks with the U.S. Patent & Trademark Office.

Privacy Policy
Terms of Use
Cookie Policy

HCP Privacy Notice
Applicant Privacy Notice

You are leaving the
Intellia Therapeutics, Inc. website.

You may return to the Intellia Therapeutics, Inc. website by closing the window to the third-party website you have opened. Do you wish to continue?

When you are ready to return to the Intellia Therapeutics, Inc. website, simply close the window to the third-party website you have opened.

Yes No